Stocks and Investing Stocks and Investing
Fri, June 14, 2024
Thu, June 13, 2024
Wed, June 12, 2024
Tue, June 11, 2024

Andy Chen Initiated (VRDN) at Buy on, Jun 11th, 2024


Published on 2024-10-28 11:52:49 - WOPRAI, Andy Chen
  Print publication without navigation


Andy Chen of Wolfe Research, Initiated "Viridian Therapeutics, Inc." (VRDN) at Buy on, Jun 11th, 2024.

Andy has made no other calls on VRDN in the last 4 months.



There are 6 other peers that have a rating on VRDN. Out of the 6 peers that are also analyzing VRDN, 2 agree with Andy's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Kalpit Patel of "B. Riley Securities" Downgraded from Strong Buy to Hold and Decreased Target to $20 on, Thursday, May 9th, 2024
  • Michael Higgins of "Ladenburg Thalmann" Downgraded from Strong Buy to Hold on, Thursday, May 9th, 2024


These are the ratings of the 4 analyists that currently disagree with Andy


  • Richard Law of "Goldman Sachs" Initiated at Strong Buy and Held Target at $23 on, Thursday, June 6th, 2024
  • Douglas Tsao of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $27 on, Thursday, May 9th, 2024
  • Leland Gershell of "Oppenheimer" Maintained at Buy with Decreased Target to $31 on, Thursday, May 9th, 2024
  • Laura Chico of "Wedbush" Maintained at Buy with Increased Target to $40 on, Wednesday, February 28th, 2024